Evidence map›Paper›PMID 34648513›Full record

ArticlePloS one2021

Prediction of viral symptoms using wearable technology and artificial intelligence: A pilot study in healthcare workers.

Pierre-François D'Haese, Victor Finomore, Dmitry Lesnik, Laura Kornhauser, Tobias Schaefer, Peter E Konrad, Sally Hodder, Clay Marsh, Ali R Rezai

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pierre-François D'HaeseRockefeller Neuroscience Institute, West Virginia University, Morgantown, West Virginia, United States of America.ORCID 0000-0003-2027-3009
Victor FinomoreRockefeller Neuroscience Institute, West Virginia University, Morgantown, West Virginia, United States of America.ORCID 0000-0002-9884-1152
Dmitry LesnikStratyfy, Inc, New York, New York, United States of America.ORCID 0000-0001-6392-2844
Laura KornhauserStratyfy, Inc, New York, New York, United States of America.
Tobias SchaeferStratyfy, Inc, New York, New York, United States of America.
Peter E KonradRockefeller Neuroscience Institute, West Virginia University, Morgantown, West Virginia, United States of America.
Sally HodderRockefeller Neuroscience Institute, West Virginia University, Morgantown, West Virginia, United States of America.
Clay MarshRockefeller Neuroscience Institute, West Virginia University, Morgantown, West Virginia, United States of America.
Ali R RezaiRockefeller Neuroscience Institute, West Virginia University, Morgantown, West Virginia, United States of America.

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

Conventional testing and diagnostic methods for infections like SARS-CoV-2 have limitations for population health management and public policy. We hypothesize that daily changes in autonomic activity, measured through off-the-shelf technologies together with app-based cognitive assessments, may be used to forecast the onset of symptoms consistent with a viral illness. We describe our strategy using an AI model that can predict, with 82% accuracy (negative predictive value 97%, specificity 83%, sensitivity 79%, precision 34%), the likelihood of developing symptoms consistent with a viral infection three days before symptom onset. The model correctly predicts, almost all of the time (97%), individuals who will not develop viral-like illness symptoms in the next three days. Conversely, the model correctly predicts as positive 34% of the time, individuals who will develop viral-like illness symptoms in the next three days. This model uses a conservative framework, warning potentially pre-symptomatic individuals to socially isolate while minimizing warnings to individuals with a low likelihood of developing viral-like symptoms in the next three days. To our knowledge, this is the first study using wearables and apps with machine learning to predict the occurrence of viral illness-like symptoms. The demonstrated approach to forecasting the onset of viral illness-like symptoms offers a novel, digital decision-making tool for public health safety by potentially limiting viral transmission.

Indexed as

Artificial IntelligenceHealth PersonnelModels, TheoreticalWearable Electronic DevicesCOVID-19HumansMachine LearningPilot ProjectsSensitivity and Specificity

Identifiers

PMID34648513
PMCPMC8516235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.